References
Argiropoulos B, Yung E, Humphries RK . Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev 2007; 21: 2845–2849.
Pineault N, Helgason CD, Lawrence HJ, Humphries RK . Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 2002; 30: 49–57.
Watkins NA, Gusnanto A, de Bono B, De S, Miranda-Saavedra D, Hardie DL et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 2009; 113: e1–e9.
Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G . Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001; 21: 224–234.
Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011; 17: 1086–1093.
Pineault N, Abramovich C, Ohta H, Humphries RK . Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 2004; 24: 1907–1917.
Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML . Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 2007; 21: 2762–2774.
Kumar AR, Sarver AL, Wu B, Kersey JH . Meis1 maintains stemness signature in MLL-AF9 leukemia. Blood 2010; 115: 3642–3643.
Xiang P, Lo C, Argiropoulos B, Lai CB, Rouhi A, Imren S et al. Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1. Exp Hematol 2010; 38: 798–798, 808 e1-2.
Royo JL, Bessa J, Hidalgo C, Fernandez-Minan A, Tena JJ, Roncero Y et al. Identification and analysis of conserved cis-regulatory regions of the MEIS1 gene. PloS One 2012; 7: e33617.
Wang QF, Li YJ, Dong JF, Li B, Kaberlein JJ, Zhang L et al. Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia, e-pub ahead of print 15 October 2013; doi:10.1038/leu.2013.260.
Ernst J, Kellis M . Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010; 28: 817–825.
Kulaeva OI, Nizovtseva EV, Polikanov YS, Ulianov SV, Studitsky VM . Distant activation of transcription: mechanisms of enhancer action. Mol Cell Biol 2012; 32: 4892–4897.
Phillips JE, Corces VG . CTCF: master weaver of the genome. Cell 2009; 137: 1194–1211.
Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rgammac-deficient mice. J Clin Investig 2011; 121: 384–395.
Acknowledgements
We sincerely thank other lab members in Dr Keith Humphries’ laboratory for helpful discussion. This work is supported by the Terry Fox Foundation Program Project Grant (TFF-122869) and CIHR (RMF-92093).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Xiang, P., Wei, W., Lo, C. et al. Delineating MEIS1 cis-regulatory elements active in hematopoietic cells. Leukemia 28, 433–436 (2014). https://doi.org/10.1038/leu.2013.287
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.287
- Springer Nature Limited